KATHERINE O'NEAL: Open Payments
NPI 1205486339 · BESSEMER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 24 payments from 8 companies in 2025. Trend: 2023 $449 · 2024 $723 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $309 |
| Merck Sharp & Dohme LLC | 5 | $105 |
| Edwards Lifesciences Corporation | 2 | $67 |
| SCPHARMACEUTICALS INC. | 3 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $15 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $11 |
Products named: LEQVIO, VERQUVO, SAPIEN 3 Ultra RESILIA, FUROSCIX, JARDIANCE, OPSUMIT, CAPVAXIVE, ELIQUIS.
Industry payments across AL — which companies pay providers there.
